Linden sees 8x return on original HydraFacial investment amid $1.1bn SPAC merger
Dec 09, 2020 - peHUB
Mergers and Acquisitions
As HydraFacial agrees to merge with Vester Healthcare Acquisition Corp, Linden Capital Partners has so far generated an 8x return on original invested capital based on the SPAC's current share price, LP sources with knowledge of the matter told PE Hub.
The pending transaction, announced Wednesday, implies an initial enterprise value of $1.1 billion for HydraFacial, whose 30-minute signature facial is likened to a medical treatment and viewed as an alternative to microdermabrasion.
Vester was co-founded by Brent Saunders, who is not only an industry veteran but an experienced dealmaker as the former CEO of Allergan, Forest Laboratories, and Bausch + Lomb. The former is best known as the maker of Botox injections...
Sign up today to gain access to 5 free articles a month from over 200 top subscription outlets.
Are you ready to take your business development to the next level with RelSci Professional?
Nurture your network with daily alerts that notify you when your relationships make news
Map your relationships to any target or prospect to identify a warm introduction
Access unlimited deep dossiers on over 8 million decision makers
Best of all, you can try out all these powerful business development tools absolutely free for 30 days!
Check out News Home to stay on top of the people and organizations you care most about.
